Managing treatment–related adverse events associated with Alk inhibitors

Por Rothenstein, J.M., Letarte, N.
Publicado em 2014

Community paediatricians' counseling patterns and knowledge of recommendations relating to child restraint use in motor vehicles

Por Rothenstein, J, Howard, A, Parkin, P, Khambalia, A, Macarthur, C
Publicado em 2004

Management of egfr tki–induced dermatologic adverse events

Por Melosky, B., Leighl, N.B., Rothenstein, J., Sangha, R., Stewart, D., Papp, K.
Publicado no Curr Oncol (2015)

Treatment patterns and survival in patients with ALK-positive non-small-cell lung cancer: a Canadian retrospective study

Por Kayaniyil, S., Hurry, M., Wilson, J., Wheatley-Price, P., Melosky, B., Rothenstein, J., Cohen, V., Koch, C., Zhang, J., Osenenko, K., Liu, G.
Publicado no Curr Oncol (2016)